Hint mode is switched on Switch off

Disc Medicine, ordinary share
GMTX, US36870G1058

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Disc Medicine, сountry — USA
30/12/2022 stock stopped trading due to affiliation to Disc Medicine, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Issuer

Profile
Disc Medicine, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. Disc Medicine develops therapeutic candidates that aim to address ...
Disc Medicine, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. Disc Medicine develops therapeutic candidates that aim to address spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology.
  • Issuer
  • Full borrower / issuer name
    Disc Medicine Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology
Registration is required to get access.